APA (7th ed.) Citation

Dimopoulos, M. A., Dytfeld, D., Grosicki, S., Moreau, P., Takezako, N., Hori, M., . . . Raab, M. (2018). Elotuzumab plus pomalidomide and dexamethasone for multiple myeloma. The New England journal of medicine, 379(19), . https://doi.org/10.1056/NEJMoa1805762

Chicago Style (17th ed.) Citation

Dimopoulos, Meletios A., et al. "Elotuzumab Plus Pomalidomide and Dexamethasone for Multiple Myeloma." The New England Journal of Medicine 379, no. 19 (2018). https://doi.org/10.1056/NEJMoa1805762.

MLA (9th ed.) Citation

Dimopoulos, Meletios A., et al. "Elotuzumab Plus Pomalidomide and Dexamethasone for Multiple Myeloma." The New England Journal of Medicine, vol. 379, no. 19, 2018, https://doi.org/10.1056/NEJMoa1805762.